Clinical Trials for Molecularly Targeted Cancer Therapeutics
Venue: Washington DC
Location: Washington DC, United States
Event Date/Time: Jan 26, 2004 | End Date/Time: Jan 28, 2004 |
Description
Tak Mak, Ph.D.
Director
Division of Cellular and Molecular Biology
AMDI Institute, PMH
Monday January 26, 2003 Two Pre-Conference Workshops:
Strategies to Meeting Recruitment Rates and Overcoming Patient Enrollment Obstacles
Lead by Michael Schuster, MD, Director of Clinical Trials, Division of Hematology/Oncology
NEW YORK PRESBYTERIAN HOSPITAL
Medical Imaging
Lead by Ivan Horak, PhD CEO
IMMUNOMEDICS
Full speakers list for these workshops will be available soon.
Advisory Board Members:
Larry Blankstein, PhD Senior Director of Clinical Development ,Oncology
GENZYME
Steven Hamburger, Senior Director and Global Regulatory Strategic Leader Oncology Department
JOHNSON & JOHNSON PHARMACEUTICAL R&D
Ivan Horak, MD, Executive Vice President, Research and Development
IMMUNOMEDICS
Gary Schwartz, PHD
MEMORIAL SLOAN KETTERING CANCER CENTER
Fabio Benedetti , PhD, VP of Global Medical Affairs
MILLENNIUM PHARMACEUTICALS
Elise Kohn, PhD
NATIONAL CANCER INSTITUTE
Michael Schuster, MD, Director of Clinical Trials Division of Hematology/Oncology
NEW YORK PRESBYTERIAN HOSPITAL
William Gradishar Associate Professor of Medicine Division of Hematology and Medical Oncology
NORTHWESTERN UNIVERSITY
Lee Allen, PhD, Director of Oncology
WYETH